Zobrazeno 1 - 10
of 126
pro vyhledávání: '"María Sereno"'
Autor:
María Sereno, Silvia Roa Franco, Laura de la Reina, José Luis Campo-Cañaveral de la Cruz, Marta Muñoz de Legaría, Enrique Casado Saénz
Publikováno v:
Current Oncology, Vol 30, Iss 10, Pp 9335-9345 (2023)
Giant cell tumors of bone are a rare entity, usually occurring in young patients and characteristically arising in the long bones. The spinal location is rare and usually presents with pain and/or neurological symptoms. The treatment of choice is sur
Externí odkaz:
https://doaj.org/article/7824de77f8fe49398e9a8092eeca5156
Autor:
María Merino Salvador, Lara Paula Fernández, Juan Moreno-Rubio, Gonzalo Colmenarejo, Enrique Casado, Ana Ramírez de Molina, María Sereno
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background Lung cancer is one of the most lethal tumors with a poor survival rate even in those patients receiving new therapies. Metabolism is considered one of the hallmarks in carcinogenesis and lipid metabolism is emerging as a significa
Externí odkaz:
https://doaj.org/article/930f2f39789741ce96e897d9a8f3fb99
Autor:
María Sereno, Jose M Iniesta-Chamorro, Beatriz Garrido-Rubiales, Enrique Javier Gomez, Enrique Casado Sáenz
Publikováno v:
SAGE Open Medicine, Vol 11 (2023)
The internet and digital technology have become an important resource for patients with cancer. Mobile health strategies permit patients and clinicians to interact via different tools to enrich the supplements to routine hospital visits or out-patien
Externí odkaz:
https://doaj.org/article/d98e8ba91d9f48e5ae9c5938c14ce752
Autor:
Adrián Bouzas, Marta Gómez de Cedrón, Gonzalo Colmenarejo, José Moisés Laparra-Llopis, Juan Moreno-Rubio, Juan José Montoya, Guillermo Reglero, Enrique Casado, Beatriz Tabares, María Sereno, Ana Ramírez de Molina
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Lung cancer is one of the most deadly and common cancers in the world. The molecular features of patient’s tumours dictate the different therapeutic decisions, which combines targeted therapy, chemotherapy, and immunotherapy. Altered cellular metab
Externí odkaz:
https://doaj.org/article/9e924016011f49f8b997b37429a4aaff
Autor:
Isabel Espinosa, Marta Gómez de Cedrón, Jose Iniesta, María Sereno, Enrique Gómez, Guillermo Reglero, Ana Ramírez de Molina
Publikováno v:
Revista Española de Nutrición Humana y Dietética, Vol 25, Iss Sup. 3 (2021)
Externí odkaz:
https://doaj.org/article/8c39a901a6b54b7b89cbfa478fc63612
Autor:
Roberto Serna-Blasco, Estela Sánchez-Herrero, Lucía Robado de Lope, Sandra Sanz-Moreno, Alejandro Rodríguez-Festa, Dunixe Ares-Trotta, Alberto Cruz-Bermúdez, Fabio Franco, Alfredo Sánchez-Hernández, María de Julián Campayo, Carlos García-Girón, Manuel Dómine, Ana Blasco, José M. Sánchez, Juana Oramas, Joaquim Bosch-Barrera, María Á. Sala, María Sereno, Atocha Romero, Mariano Provencio
Publikováno v:
Cancers, Vol 14, Iss 18, p 4446 (2022)
Tumor molecular profiling upon disease progression enables investigations of the tumor evolution. Next-generation sequencing (NGS) of liquid biopsies constitutes a noninvasive readily available source of tumor molecular information. In this study, 12
Externí odkaz:
https://doaj.org/article/fbefb4723b93488996868c6f1d0d8a8d
Autor:
María Sereno, Ana María Jimenez-Gordo, Javier Baena-Espinar, Carlos Aguado, Xabier Mielgo, Ana Pertejo, Rosa Álvarez-Álvarez, Ana Sánchez, Jose Luis López, Raquel Molina, Ana López-Alfonso, Berta Hernández, Luis Enrique Chiara, Ana Manuela Martín, Ana López-Martín, Miriam Dorta, Ana Collazo-Lorduy, Enrique Casado, Ana Ramirez de Molina, Gonzalo Colmenarejo
Publikováno v:
Cancers, Vol 13, Iss 16, p 4205 (2021)
Background: Approximately 15% of patients infected by SARS-CoV-2 develop a distress syndrome secondary to a host hyperinflammatory response induced by a cytokine storm. Myelosuppression is associated with a higher risk of infections and mortality. Th
Externí odkaz:
https://doaj.org/article/02baa3a73caa40f08f7f2009094aefe7
Autor:
Lara P. Fernández, María Merino, Gonzalo Colmenarejo, Juan Moreno Rubio, Tais González Pessolani, Guillermo Reglero, Enrique Casado, María Sereno, Ana Ramírez de Molina
Publikováno v:
Cancers, Vol 13, Iss 5, p 1112 (2021)
Small cell lung cancer (SCLC) prognosis is the poorest of all types of lung cancer. Its clinical management remains heterogeneous and therefore, the capability to predict survival would be of great clinical value. Metabolic health (MH) status and lip
Externí odkaz:
https://doaj.org/article/56eba4b0a629444f9028877e38d41f53
Autor:
María Sereno, Luis Cabezón-Gutiérrez, Oliver Higuera, Xabier Mielgo-Rubio, Raquel Cervera-Calero
Publikováno v:
Future Oncology.
Aim: To define high tumor burden (HTB) in non-small-cell lung cancer. Methods: A total of five oncologists initiated the project, selecting 66 participants, and elaborated a questionnaire with 26 statements using the Delphi method with a 9-point Like
Autor:
Cristina Rodríguez-Antona, Magnus Ingelman-Sundberg, Mercedes Robledo, Inger Johansson, Alberto Cascón, Luis J. Leandro-García, Eva Guerra, Beatriz Castelo, Jesús García-Donás, María Sereno, Laura García-Estévez, Isabel Calvo, Gerardo Gutiérrez-Gutiérrez, Lara Sánchez-Barroso, Mi-Young Lee, María Apellániz-Ruiz
Supplementary Figure 1. CYP3A4.25 protein stability assessment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66f6bfd19138fa063d71d1270272477a
https://doi.org/10.1158/1078-0432.22461834.v1
https://doi.org/10.1158/1078-0432.22461834.v1